The report, "Pharmaceutical Packaging," explains that an increased focus on these issues will drive growth for container accessories, especially parenteral vials and flip-top closures, plastic dispensing bottles and closures, prefillable inhalers and syringes, track-and-trace and authentication labels, and unit-dose pouches. Other key findings include the following:
• Advances in biotechnology will lead growth in prefillable syringes and vials, driving demand for primary pharmaceutical containers by 5.2% annually to $9.6 billion by 2012.
• Plastic bottles will remain the most-used pack for oral drugs distributed in bulk and prescription-dose volumes to retail and mail-order pharmacies.
• The market for pharmaceutical pouches will grow quickly, spurred by unit-dose packaging of transdermal patches, powders for reconstitution, and topical creams and ointments.
• Prefillable inhaler demand will rise as a result of asthma, allergy, and migraine patient needs.
• Aesthetic and barrier-property improvements will keep tubes a leading primary container for topical medication.
The 319-page report is available for $4,700 by contacting Corinne Gangloff at 440/684-9600 or [email protected].
